It is my great honor to welcome you to the International Society for Clinical and Academic Hepatology (ISCAH).​

 

Liver disease remains one of the leading and growing global health challenges, affecting millions of people across diverse regions and healthcare systems. Addressing this burden requires not only scientific progress, but also strong collaboration between clinicians, researchers, educators, and institutions worldwide. ISCAH was founded with this purpose at its core.​

 

Our society is committed to advancing excellence in hepatology through evidence-based medicine, high-quality education, and the promotion of innovative research. We aim to create a global platform that supports knowledge exchange, professional development, and meaningful collaboration across borders, regardless of geography or resource setting.​

 

ISCAH seeks to bridge clinical practice and academic science, empowering healthcare professionals to improve patient outcomes and contribute to the future of liver health. Through educational initiatives, scientific activities, and international partnerships, we strive to foster a community dedicated to reducing the global burden of liver disease.

 

I invite you to join ISCAH in this shared mission and to actively contribute to shaping a healthier future through collaboration, integrity, and scientific excellence.​

 

Dr. Tatia Khachidze

President, International Society for Clinical and Academic Hepatology (ISCAH)